Catalyst
Monitor results from the study visits and any findings related to disease progression and vascular health over the 9-year period.
Date
June 29, 2026
Phase
N/A
Status
watch
Signal score
7.0
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.